A detailed history of Canada Pension Plan Investment Board transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 661,600 shares of ACAD stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
661,600
Holding current value
$10.3 Million
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$17.79 - $30.86 $11.8 Million - $20.4 Million
661,600 New
661,600 $12.2 Million
Q2 2022

Aug 12, 2022

BUY
$13.01 - $27.22 $89,769 - $187,818
6,900 Added 12.11%
63,900 $900,000
Q1 2022

May 13, 2022

BUY
$20.94 - $27.5 $1.19 Million - $1.57 Million
57,000 New
57,000 $1.38 Million
Q4 2020

Feb 17, 2021

SELL
$41.04 - $56.79 $144,707 - $200,241
-3,526 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$36.42 - $57.0 $1.04 Million - $1.63 Million
-28,554 Reduced 89.01%
3,526 $145,000
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $851,156 - $1.14 Million
21,680 Added 208.46%
32,080 $1.56 Million
Q1 2020

May 13, 2020

SELL
$31.65 - $46.87 $263,707 - $390,520
-8,332 Reduced 44.48%
10,400 $439,000
Q4 2019

Feb 14, 2020

BUY
$36.21 - $51.4 $122,932 - $174,503
3,395 Added 22.14%
18,732 $801,000
Q3 2019

Nov 12, 2019

SELL
$22.22 - $44.01 $254,618 - $504,310
-11,459 Reduced 42.76%
15,337 $552,000
Q2 2019

Aug 12, 2019

SELL
$23.32 - $28.12 $1.62 Million - $1.96 Million
-69,604 Reduced 72.2%
26,796 $716,000
Q1 2019

May 15, 2019

SELL
$16.17 - $27.38 $14,553 - $24,642
-900 Reduced 0.92%
96,400 $2.59 Million
Q4 2018

Feb 06, 2019

BUY
$14.32 - $22.92 $185,644 - $297,134
12,964 Added 15.37%
97,300 $1.57 Million
Q3 2018

Nov 09, 2018

SELL
$13.03 - $21.81 $4.92 Million - $8.24 Million
-377,864 Reduced 81.75%
84,336 $1.75 Million
Q1 2017

Jan 31, 2018

BUY
N/A
462,200
462,200 $15.9 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.52B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.